Public misinformed about seal of approval from US drug agency
Efthimi Parasidis explores JAMA’s spotlight on FDA, Drugs, and Devices at The Conversation, a London-based news outlet. Click here to go to the article.
Public Health
-
Read more: Public misinformed about seal of approval from US drug agency -
Read more: Book Review: Pharmaceutical Innovation, Competition and Patent Law – A Trilateral Perspective Book Review: Pharmaceutical Innovation, Competition and Patent Law – A Trilateral Perspective
By Timo Minssen Following a request by the European Competition Law Review (Sweet Maxwell), I have today submitted a review of the recent publication “Pharmaceutical Innovation, Competition and Patent Law – A Trilateral Perspective”, edited by Max Planck Director Josef Drexl and Finnish scholar Nari Lee (Edward Elgar 2013, 322 p., ISBN 978 0 85793…
-
Read more: Infrastructure as a Social Determinant of Health in Developing Economies Infrastructure as a Social Determinant of Health in Developing Economies
By Matthew L Baum Recently in the New England Journal of Medicine, D.S. Jones described the history of a dangerous new technology, the detrimental health effects of which had clinicians very worried. That technology was the automobile. While the public health concern spanned from inactivity to new maladies like “automobile knee”, by far the greatest concern…
-
Read more: Managed Care for Mental Health Managed Care for Mental Health
By Nathaniel Counts Managed care and integration of primary care and mental health services are major foci of the Affordable Care Act, especially as more practices are encouraged to become Patient-Centered Medical Homes. In managed care, vitals are used to track progress, and case managers can look over an individual’s blood pressure, weight, and blood-sugar…
-
Read more: Genetically Modified Crops Genetically Modified Crops
By Jeffrey Skopek The USDA’s Animal and Plant Health Inspection Service (APHIS) has released a Draft Environmental Impact Statement associated with its deregulation of a new generation of genetically modified herbicide-resistant crops. While many in the agricultural industry hail this as a much-needed step in the development of new weed-control technologies, critics worry that it…
-
Read more: REGISTER NOW: “New Directions for Food Safety” conference at Harvard Law School REGISTER NOW: “New Directions for Food Safety” conference at Harvard Law School
This conference will bring together scholars to discuss a range of issues related to the Food Safety and Modernization Act, including FSMA and risk regulation strategy; regulating farm production; benefits, challenges, and gaps in FSMA’s approach; and international issues and trade implications. Speakers include: KEYNOTE: Peter Barton Hutt, Harvard Law School/Covington & Burling – The Food Safety…
-
Read more: Quantitative Analytical Support Needed for Public Health Law Research Quantitative Analytical Support Needed for Public Health Law Research
By Temple University Center for Public Health Law Research The National Program Office (NPO) for Public Health Law Research (PHLR), a nationally recognized program sponsored by Robert Wood Johnson Foundation for the evaluation of the health impact of laws and legal practices, seeks a postdoctoral fellow who will provide quantitative analytical support to the PHLR…
-
Read more: Down with Antipaternalism! Down with Antipaternalism!
By Scott Burris As the holidays approach, I have a chance to catch up on reading. The Sept-Oct issue of the Hastings Center Report had a paper by Larry Gostin on Michael Bloomberg’s health policy career in New York, and I have seen some of a series of responses by other scholars that will appear…
-
Read more: Managing All Care Managing All Care
By Nathaniel Counts Health insurers are beginning to realize the importance of downstream cost-saving. By paying to keep people healthy now, health insurers avoid major expenditures later when they must cover chronic conditions and hospitalizations. For example, by paying for nutrition counseling and fitness programs for prediabetics, health insurers can reduce the rate of transition…
-
Read more: 1/31: Second Annual Health Law Year in P/Review conference 1/31: Second Annual Health Law Year in P/Review conference
Please join us for our second annual Health Law Year in P/Review event, co-sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the New England Journal of Medicine. The conference will be held in Wasserstein Hall, Milstein East C at Harvard Law School on Friday, January 31, 2014, from 8:30am to 5:00pm. This…